Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Safety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene: results of a phase 1/2 Study.

Autor: Mease PJ; Seattle Rheumatology Associates, Swedish Medical Center, Seattle, Wahington 98104, USA. pmease@nwlink.com, Wei N, Fudman EJ, Kivitz AJ, Schechtman J, Trapp RG, Hobbs KF, Greenwald M, Hou A, Bookbinder SA, Graham GE, Wiesenhutter CW, Willis L, Ruderman EM, Forstot JZ, Maricic MJ, Dao KH, Pritchard CH, Fiske DN, Burch FX, Prupas HM, Anklesaria P, Heald AE

Publikováno v: The Journal of rheumatology [J Rheumatol] 2010 Apr; Vol. 37 (4), pp. 692-703. Date of Electronic Publication: 2009 Dec 23.

Acromegalic arthropathy. Characteristics and response to therapy.

Autor: Layton MW; Rackham Arthritis Research Unit, Department of Internal Medicine, University Hospital, Ann Arbor, Michigan 48109-0108., Fudman EJ, Barkan A, Braunstein EM, Fox IH

Publikováno v: Arthritis and rheumatism [Arthritis Rheum] 1988 Aug; Vol. 31 (8), pp. 1022-7.

Deferoxamine induced decreases of lipid peroxides in rheumatoid arthritis.

Autor: Fudman EJ; Rackham Arthritis Research Unit, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor., Till GO, Fox IH

Publikováno v: The Journal of rheumatology [J Rheumatol] 1987 Aug; Vol. 14 (4), pp. 686-91.

Scleromyxedema with systemic involvement mimics rheumatic diseases.

Autor: Fudman EJ, Golbus J, Ike RW

Publikováno v: Arthritis and rheumatism [Arthritis Rheum] 1986 Jul; Vol. 29 (7), pp. 913-7.